CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 80 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $6,355,649 | -12.8% | 1,088,296 | 0.0% | 0.13% | -17.3% |
Q3 2022 | $7,292,000 | -47.6% | 1,088,296 | -67.1% | 0.16% | -58.0% |
Q2 2022 | $13,923,000 | +36.2% | 3,307,203 | +9.0% | 0.37% | +66.4% |
Q1 2022 | $10,223,000 | +7.0% | 3,033,603 | 0.0% | 0.22% | +32.7% |
Q4 2021 | $9,556,000 | -3.7% | 3,033,603 | 0.0% | 0.17% | +22.6% |
Q3 2021 | $9,920,000 | -22.5% | 3,033,603 | 0.0% | 0.14% | -33.2% |
Q2 2021 | $12,802,000 | -15.4% | 3,033,603 | 0.0% | 0.20% | -10.1% |
Q1 2021 | $15,138,000 | -34.3% | 3,033,603 | +66.4% | 0.23% | -29.2% |
Q4 2020 | $23,049,000 | +26.3% | 1,823,520 | -1.9% | 0.32% | -3.6% |
Q3 2020 | $18,250,000 | -1.3% | 1,858,474 | 0.0% | 0.33% | -7.2% |
Q2 2020 | $18,492,000 | +12.6% | 1,858,474 | 0.0% | 0.36% | -30.6% |
Q1 2020 | $16,429,000 | +65.1% | 1,858,474 | +178.0% | 0.52% | -48.2% |
Q2 2015 | $9,953,000 | -0.4% | 668,406 | +1.3% | 1.00% | +0.8% |
Q1 2015 | $9,996,000 | – | 660,000 | – | 0.99% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |